ChloroquineV1, Main, Exploration, bibRecord, 002036

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Identifieur interne : 002036 ( Main/Exploration ); précédent : 002035; suivant : 002037

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Auteurs : Ahmed S. Samad [États-Unis] ; Carol B. Lindsley

Source :

Southern medical journal [ 0038-4348 ] ; 2003.

RBID : pubmed:12940327

Descripteurs français

KwdFr :
- Acide mycophénolique (analogues et dérivés), Acide mycophénolique (usage thérapeutique), Adolescent, Association de médicaments, Association thérapeutique, Glomérulonéphrite lupique (diagnostic), Glomérulonéphrite lupique (traitement médicamenteux), Humains, Hydroxychloroquine (usage thérapeutique), Hémorragie (diagnostic), Hémorragie (traitement médicamenteux), Immunosuppresseurs (usage thérapeutique), Lupus érythémateux disséminé (diagnostic), Lupus érythémateux disséminé (traitement médicamenteux), Maladies pulmonaires (diagnostic), Maladies pulmonaires (traitement médicamenteux), Mâle, Méthylprednisolone (usage thérapeutique), Perfusions veineuses, Plasmaphérèse, Prednisone (usage thérapeutique), Ventilation artificielle, Évolution de la maladie.
MESH :
- analogues et dérivés : Acide mycophénolique.
- diagnostic : Glomérulonéphrite lupique, Hémorragie, Lupus érythémateux disséminé, Maladies pulmonaires.
- traitement médicamenteux : Glomérulonéphrite lupique, Hémorragie, Lupus érythémateux disséminé, Maladies pulmonaires.
- usage thérapeutique : Acide mycophénolique, Hydroxychloroquine, Immunosuppresseurs, Méthylprednisolone, Prednisone.
- Adolescent, Association de médicaments, Association thérapeutique, Humains, Mâle, Perfusions veineuses, Plasmaphérèse, Ventilation artificielle, Évolution de la maladie.

English descriptors

KwdEn :
- Adolescent, Combined Modality Therapy, Disease Progression, Drug Therapy, Combination, Hemorrhage (diagnosis), Hemorrhage (drug therapy), Humans, Hydroxychloroquine (therapeutic use), Immunosuppressive Agents (therapeutic use), Infusions, Intravenous, Lung Diseases (diagnosis), Lung Diseases (drug therapy), Lupus Erythematosus, Systemic (diagnosis), Lupus Erythematosus, Systemic (drug therapy), Lupus Nephritis (diagnosis), Lupus Nephritis (drug therapy), Male, Methylprednisolone (therapeutic use), Mycophenolic Acid (analogs & derivatives), Mycophenolic Acid (therapeutic use), Plasmapheresis, Prednisone (therapeutic use), Respiration, Artificial.
MESH :
- chemical , analogs & derivatives : Mycophenolic Acid.
- chemical , therapeutic use : Hydroxychloroquine, Immunosuppressive Agents, Methylprednisolone, Mycophenolic Acid, Prednisone.
- diagnosis : Hemorrhage, Lung Diseases, Lupus Erythematosus, Systemic, Lupus Nephritis.
- drug therapy : Hemorrhage, Lung Diseases, Lupus Erythematosus, Systemic, Lupus Nephritis.
- Adolescent, Combined Modality Therapy, Disease Progression, Drug Therapy, Combination, Humans, Infusions, Intravenous, Male, Plasmapheresis, Respiration, Artificial.

Abstract

Systemic lupus erythematosus is a chronic autoimmune disease of unknown etiology with multisystem involvement. Pulmonary hemorrhage is a major life-threatening manifestation in children and adolescents with systemic lupus erythematosus, as well as in adults. Treatment has traditionally been with high-dose corticosteroids, with or without the addition of cytotoxic agents. We report the response of a patient with childhood systemic lupus erythematosus with recurrent pulmonary hemorrhage to treatment with mycophenolate mofetil.

DOI: 10.1097/01.SMJ.0000054424.20202.7D
PubMed: 12940327

Affiliations:

États-Unis

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.</title>
<author><name sortKey="Samad, Ahmed S" sort="Samad, Ahmed S" uniqKey="Samad A" first="Ahmed S" last="Samad">Ahmed S. Samad</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160-7330, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160-7330</wicri:regionArea>
<wicri:noRegion>Kansas 66160-7330</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lindsley, Carol B" sort="Lindsley, Carol B" uniqKey="Lindsley C" first="Carol B" last="Lindsley">Carol B. Lindsley</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12940327</idno>
<idno type="pmid">12940327</idno>
<idno type="doi">10.1097/01.SMJ.0000054424.20202.7D</idno>
<idno type="wicri:Area/PubMed/Corpus">000461</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000461</idno>
<idno type="wicri:Area/PubMed/Curation">000461</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000461</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000436</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000436</idno>
<idno type="wicri:Area/Ncbi/Merge">000037</idno>
<idno type="wicri:Area/Ncbi/Curation">000037</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000037</idno>
<idno type="wicri:doubleKey">0038-4348:2003:Samad A:treatment:of:pulmonary</idno>
<idno type="wicri:Area/Main/Merge">002052</idno>
<idno type="wicri:Area/Main/Curation">002036</idno>
<idno type="wicri:Area/Main/Exploration">002036</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.</title>
<author><name sortKey="Samad, Ahmed S" sort="Samad, Ahmed S" uniqKey="Samad A" first="Ahmed S" last="Samad">Ahmed S. Samad</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160-7330, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160-7330</wicri:regionArea>
<wicri:noRegion>Kansas 66160-7330</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lindsley, Carol B" sort="Lindsley, Carol B" uniqKey="Lindsley C" first="Carol B" last="Lindsley">Carol B. Lindsley</name>
</author>
</analytic>
<series><title level="j">Southern medical journal</title>
<idno type="ISSN">0038-4348</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Combined Modality Therapy</term>
<term>Disease Progression</term>
<term>Drug Therapy, Combination</term>
<term>Hemorrhage (diagnosis)</term>
<term>Hemorrhage (drug therapy)</term>
<term>Humans</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Infusions, Intravenous</term>
<term>Lung Diseases (diagnosis)</term>
<term>Lung Diseases (drug therapy)</term>
<term>Lupus Erythematosus, Systemic (diagnosis)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Lupus Nephritis (diagnosis)</term>
<term>Lupus Nephritis (drug therapy)</term>
<term>Male</term>
<term>Methylprednisolone (therapeutic use)</term>
<term>Mycophenolic Acid (analogs & derivatives)</term>
<term>Mycophenolic Acid (therapeutic use)</term>
<term>Plasmapheresis</term>
<term>Prednisone (therapeutic use)</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide mycophénolique (analogues et dérivés)</term>
<term>Acide mycophénolique (usage thérapeutique)</term>
<term>Adolescent</term>
<term>Association de médicaments</term>
<term>Association thérapeutique</term>
<term>Glomérulonéphrite lupique (diagnostic)</term>
<term>Glomérulonéphrite lupique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Hémorragie (diagnostic)</term>
<term>Hémorragie (traitement médicamenteux)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Lupus érythémateux disséminé (diagnostic)</term>
<term>Lupus érythémateux disséminé (traitement médicamenteux)</term>
<term>Maladies pulmonaires (diagnostic)</term>
<term>Maladies pulmonaires (traitement médicamenteux)</term>
<term>Mâle</term>
<term>Méthylprednisolone (usage thérapeutique)</term>
<term>Perfusions veineuses</term>
<term>Plasmaphérèse</term>
<term>Prednisone (usage thérapeutique)</term>
<term>Ventilation artificielle</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Mycophenolic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxychloroquine</term>
<term>Immunosuppressive Agents</term>
<term>Methylprednisolone</term>
<term>Mycophenolic Acid</term>
<term>Prednisone</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Acide mycophénolique</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemorrhage</term>
<term>Lung Diseases</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Lupus Nephritis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Glomérulonéphrite lupique</term>
<term>Hémorragie</term>
<term>Lupus érythémateux disséminé</term>
<term>Maladies pulmonaires</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hemorrhage</term>
<term>Lung Diseases</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Lupus Nephritis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Glomérulonéphrite lupique</term>
<term>Hémorragie</term>
<term>Lupus érythémateux disséminé</term>
<term>Maladies pulmonaires</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acide mycophénolique</term>
<term>Hydroxychloroquine</term>
<term>Immunosuppresseurs</term>
<term>Méthylprednisolone</term>
<term>Prednisone</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Combined Modality Therapy</term>
<term>Disease Progression</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Infusions, Intravenous</term>
<term>Male</term>
<term>Plasmapheresis</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Association de médicaments</term>
<term>Association thérapeutique</term>
<term>Humains</term>
<term>Mâle</term>
<term>Perfusions veineuses</term>
<term>Plasmaphérèse</term>
<term>Ventilation artificielle</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Systemic lupus erythematosus is a chronic autoimmune disease of unknown etiology with multisystem involvement. Pulmonary hemorrhage is a major life-threatening manifestation in children and adolescents with systemic lupus erythematosus, as well as in adults. Treatment has traditionally been with high-dose corticosteroids, with or without the addition of cytotoxic agents. We report the response of a patient with childhood systemic lupus erythematosus with recurrent pulmonary hemorrhage to treatment with mycophenolate mofetil.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Lindsley, Carol B" sort="Lindsley, Carol B" uniqKey="Lindsley C" first="Carol B" last="Lindsley">Carol B. Lindsley</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Samad, Ahmed S" sort="Samad, Ahmed S" uniqKey="Samad A" first="Ahmed S" last="Samad">Ahmed S. Samad</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002036 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002036 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:12940327
   |texte=   Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:12940327" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

Serveur d'exploration Chloroquine

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.